Kaiser Foundation Health Plan Southern California
Caprelsa (vandetanib)
Drugs for Cancer : Drugs for Cancer
  • Quantity Limit: limit maximum 600 mL PER 30 day(s)
  • Neurogenic Orthostatic Hypotension:
    Age Requirement: >= 18
    Duration: 3 Month(s)
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialty Pharmacy Provider(s): Accredo Health Group, Inc.
    Reauthorization Required: Yes
    Duration of Reauthorization: = 1 year(s)
    Clinical Evaluation of Current Medications: No
    Baseline Blood Pressure Reading: No
    Diagnostic Evaluation: No
    Diagnosis Requirement(s): 1 of Dopamine Beta-Hydroxylase deficiency;Non-Diabetic Autonomic Neuropathy;Orthostatic Hypotension;Primary Autonomic Failure (Parkinson's, Multisystem Atrophy and Pure Autonomic Failure)
    Reauthorization Requirement(s): 1 of Decrease in dizziness;Positive response to therapy